I disagree as whilst news very positive for spec investment it won't attract big investors on that news alone as still a lot of uncertainty with no deals or specific clinical studies results.
Until then it will be a slow build and not a quick rocket. The game changer will be when gets in realm to attract big investors (and see changes in substantial holding notices)